Related Experiment Videos

Activation of a histone H1 kinase by tyrosine phosphorylation in v-src-transformed fibroblasts

D W Sternberg1, G Scholz, Y Fukui

  • 1Laboratory of Molecular Oncology, Rockefeller University, New York, NY 10021.

The EMBO Journal
|January 1, 1993
PubMed

Insights

Researchers identified a novel histone H1 kinase regulated by tyrosine phosphorylation in v-src-transformed cells. This kinase activity is significantly elevated and crucial for early v-src transformation events.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • v-src oncogene is known to induce cellular transformation.
  • Tyrosine phosphorylation plays a critical role in regulating protein function during cell signaling.

Purpose of the Study:

  • To identify serine/threonine kinases directly regulated by tyrosine phosphorylation in v-src-transformed cells.
  • To characterize the properties and role of such a kinase in v-src-mediated transformation.

Main Methods:

  • Anti-phosphotyrosine immunoaffinity chromatography was used to isolate tyrosine-phosphorylated proteins.
  • Histone H1 kinase activity was assayed in vitro.
  • MonoQ FPLC and gel filtration chromatography were employed for protein purification and size estimation.
  • Experiments with temperature-sensitive v-src mutants and tyrosine phosphatase treatment were performed.

Main Results:

  • A novel histone H1 kinase activity was identified in v-src-transformed cells, showing a 20-fold increase compared to parental cells.
  • The kinase has an estimated molecular mass of 55 kDa and its activity is dependent on tyrosine phosphorylation.
  • This tyrosine phosphorylation is an early event in v-src transformation.
  • The kinase is distinct from known cdc2 family members and other regulated kinases like MAP kinases.

Conclusions:

  • A novel serine/threonine kinase regulated by tyrosine phosphorylation is involved in v-src-induced cell transformation.
  • This kinase represents a potential new target for understanding and potentially treating cancers driven by v-src or related tyrosine kinases.

Related Concept Videos